Prosperity Capital Advisors’s Immix Biopharma IMMX Stock Holding History

Prosperity Capital Advisors’s Portfolio IMMX Stock Details IMMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$313K	Buy	+30,113	New	+$341K	0.02%	339

Other funds holding IMMX

Certuity North Palm Beach, Florida $2.13B AUM 70.4% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

Sowell Financial Services North Little Rock, Arkansas $3.12B AUM 22.73% 1-Year Est. Return

Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Compass Financial Management Tampa, Florida $926M AUM

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Newbridge Financial Services Group Boca Raton, Florida $868M AUM 42.47% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Prosperity Capital Advisors's IMMX Position: Q3 2026 in Review

Prosperity Capital Advisors opened a new position in Immix Biopharma (IMMX) in Q3 2026: 30,113 shares worth $313K. The stake represents 0.02% of the portfolio and ranks #339 among its holdings.

20 funds tracked by Wall St. Rank hold IMMX as of Q3 2026.

Prosperity Capital Advisors held 30,113 shares of Immix Biopharma worth $313K as of Q3 2026.
Immix Biopharma was a new Prosperity Capital Advisors position in Q3 2026.
Immix Biopharma made up 0.02% of Prosperity Capital Advisors's portfolio in Q3 2026, its #339 holding.
20 funds tracked by Wall St. Rank held Immix Biopharma as of Q3 2026.

Based on Prosperity Capital Advisors's 13F filing for Q3 2026, filed 14 Oct 2026.